Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Ind-Swift Laboratories Limited
INDSWFTLAB | NSE
137.40
INR-0.57
-0.41%
INDSWFTLAB | NSE
Loading StockChartView...
About Ind-Swift Laboratories Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
24/04/2026
Close
137.40
Open
139.00
High
142.80
Low
134.41
Ind-Swift Laboratories Limited develops manufactures and sells active pharmaceutical ingredients (APIs) and advanced intermediates in India. The company offers APIs in various therapeutic areas including macrolide antibiotic cardiovascular antihistaminic antidiabetic antipsychotic bone resorption inhibitor antimigraine Parkinson disease hyperparathyrodism analgesic aromatase inhibitor nootropic antidiarrhoeal/antiprotozoal anticholinergic sedative hypnotic and antineoplastic as well as various products for ADHD symptoms. It also provides reference standards and impurities for acamprosate calcium anastrozole aripiprazole aripiprazole atorvastatin calcium bexarotene cinacalcet hydrochloride clopidogrel bisulphate Clarithromycin ezetimibe fexofenadine hydrochloride imatinib mesylate ivabradine hydrochloride ivabradine oxalate letrozole mecloxamine citrate naratriptan hydrochloride nitazoxanide quetiapine ropinirole hydrochloride rosuvastatin calcium saxagliptin monohydrate silodosin and temozolomide as well as contract research and manufacturing services. The company also exports its products. The company was incorporated in 1995 and is headquartered in Manimajra India.
View LessINDSWFTLAB | NSE
Risk
67.3
Sharpe
1.03
Luna's Score
49/100
Recommendation
Hold
Luna says (INDSWFTLAB | NSE)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
66.1%1 month
67.3%3 months
63.9%6 months
55.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
1.92
Fwd. PE
-
Price to book
0.80
Debt to equity
0.02
Debt to assets
0.01
Ent. to EBITDA
0.49
Ent. to rev.
0.26
PEG
-
Other Fundamentals
EBITDA
1.97B
MarketCap
8.12B
MarketCap(USD)
84.86M
Div. yield
-
Op. margin
-30.12
Erngs. growth
-94.50
Rev. growth
-89.30
Ret. on equity
52.18
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
24.14
Range1M
29.50
Range3M
51.45
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.38
Price X volume
102.32M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.49 | 24.85 | Cheaper |
| Ent. to Revenue | 0.26 | 11.40 | Cheaper |
| PE Ratio | 1.92 | 51.36 | Cheaper |
| Price to Book | 0.80 | 6.83 | Cheaper |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 63.93 | 42.17 | Riskier |
| Debt to Equity | 0.02 | 0.35 | Cheaper |
| Debt to Assets | 0.01 | 0.17 | Cheaper |
| Market Cap | 8.12B | 290.82B | Emerging |
